The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis

Cardiovascular Research

Volumn 93, Issue 2, 2012, Pages 232-241

  Rodríguez, Patricia ^a   Higueras, María Angeles ^a   González Rajal, Alvaro ^b   Alfranca, Arántzazu ^b   Fierro Fernández, Marta ^a   García Fernández, Rosa Ana ^c   Ruiz Hidalgo, Maria José ^d   Monsalve, María ^e   Rodríguez Pascual, Fernando ^a,f   Redondo, Juan Miguel ^b   De La Pompa, Jose Luis ^b   Laborda, Jorge ^d   Lamas, Santiago ^a  

^a Section of Nephrology   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^e INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^f Institut Català de Ciències Cardiovasculars   (Spain)

Author keywords

Angiogenesis; Delta like 1; Endothelium; NOTCH; Pref 1

Indexed keywords

DLK1 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ECTOPIC TISSUE; EMBRYO; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG ENDOTHELIUM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETINA CELL; VASCULAR ENDOTHELIUM; ZEBRA FISH;

ANIMALS; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, NOTCH; RETINAL NEOVASCULARIZATION; SIGNAL TRANSDUCTION; WOUND HEALING; ZEBRAFISH;

EID: 84856204950     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr296     Document Type: Article

References (41)

1. Laborda J, Sausville EA, Hoffman T, Notario V. dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J Biol Chem 1993;268:3817-3820. (Pubitemid 23072906)
2. Smas CM, Sul HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993;73:725-734. (Pubitemid 23159011)
3. Sul HS. Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 2009;23:1717-1725.
4. Baladron V, Ruiz-Hidalgo MJ, Nueda ML, Diaz-Guerra MJ, Garcia-Ramirez JJ, Bonvini E et al. dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res 2005;303:343-359. (Pubitemid 40126268)
5. Bray SJ, Takada S, Harrison E, Shen SC, Ferguson-Smith AC. The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev Biol 2008;8:11.
6. Nueda ML, Garcia-Ramirez JJ, Laborda J, Baladron V. dlk1 specifically interacts with insulin-like growth factor binding protein 1 to modulate adipogenesis of 3T3-L1 cells. J Mol Biol 2008;379:428-442.
7. Sanchez-Solana B, Nueda ML, Ruvira MD, Ruiz-Hidalgo MJ, Monsalve EM, Rivero S et al. The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities. Biochim Biophys Acta 2011;1813:1153-1164.
8. Nueda ML, Baladron V, Sanchez-Solana B, Ballesteros MA, Laborda J. The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells. J Mol Biol 2007;367:1281-1293. (Pubitemid 46413261)
9. Andersen DC, Jensen L, Schroder HD, Jensen CH. 'The preadipocyte factor' DLK1 marks adult mouse adipose tissue residing vascular cells that lack in vitro adipogenic differentiation potential. FEBS Lett 2009;583:2947-2953.
10. Yevtodiyenko A, Schmidt JV. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn 2006;235:1115-1123.
11. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358:2039-2049. (Pubitemid 351656458)
12. Gridley T. Notch signaling in the vasculature. Curr Top Dev Biol 2010;92:277-309.
13. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y et al. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res 2007;100:70-78. (Pubitemid 46066775)
14. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992;89:6348-6352.
15. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature 1995;377:355-358.
16. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007;2:329-333. (Pubitemid 47040047)
17. Isaji M, Miyata H, Ajisawa Y, Takehana Y, Yoshimura N. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 1997;122:1061-1066. (Pubitemid 27494219)
18. Mikirova NA, Casciari JJ, Riordan NH. Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res 2010;2:2; doi:10.1186/2040-2384-2-2.
19. Pitulescu ME, Schmidt I, Benedito R, Adams RH. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat Protoc 2010;5: 1518-1534.
20. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002;248:307-318. (Pubitemid 35002091)
21. Parsons MJ, Pisharath H, Yusuff S, Moore JC, Siekmann AF, Lawson N et al. Notch-responsive cells initiate the secondary transition in larval zebrafish pancreas. Mech Dev 2009;126:898-912.
22. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 2002;22:5585-5592. (Pubitemid 34755767)
23. Raghunandan R, Ruiz-Hidalgo M, Jia Y, Ettinger R, Rudikoff E, Riggins P et al. Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev 2008;17:495-507. (Pubitemid 351948189)
24. Morohashi Y, Kan T, Tominari Y, Fuwa H, Okamura Y, Watanabe N et al. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl] -S-phenylglycine t-butyl ester). J Biol Chem 2006;281:14670-14676. (Pubitemid 43855171)
25. Nicoli S, Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2007; 2:2918-2923.
26. Niessen K, Fu Y, Chang L, Hoodless PA, McFadden D, Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 2008;182: 315-325.
27. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares JM, Diez J et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004;18:99-115. (Pubitemid 38090691)
28. Abdallah BM, Jensen CH, Gutierrez G, Leslie RG, Jensen TG, Kassem M. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J Bone Miner Res 2004;19: 841-852. (Pubitemid 41094396)
29. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schroder HD, Olesen JL et al. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol 2004;558:333-340. (Pubitemid 39077412)
30. Sakajiri S, O'Kelly J, Yin D, Miller CW, Hofmann WK, Oshimi K et al. Dlk1 in normal and abnormal hematopoiesis. Leukemia 2005;19:1404-1410. (Pubitemid 41136335)
31. Chen L, Qanie D, Jafari A, Taipaleemaki H, Jensen CH, Sanz ML et al. Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the AKT-dependent pathway. J Biol Chem 2011;286:32140-32149.
32. Wang Y, Zhao L, Smas C, Sul HS. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol 2010;30:3480-3492.
33. Benedito R, Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009;137: 1124-1135.
34. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 2004;18:2469-2473. (Pubitemid 39362888)
35. Suchting S, Freitas C, le Noble F, Benedito R, Breant C, Duarte A et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007;104:3225-3230. (Pubitemid 46364141)
36. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007;445:781-784. (Pubitemid 46279717)
37. Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell 2009;16:196-208.
38. D'Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene 2008;27:5148-5167.
39. Funahashi Y, Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M et al. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res 2008;68:4727-4735.
40. Dikic I, Schmidt MH. Notch: implications of endogenous inhibitors for therapy. Bioessays 2010;32:481-487.
41. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008;8:592-603.